Benchmark International Successfully Facilitates Transaction Between the sole shareholder of OMA AG and heise & dumrath medien gmbh & co. kg
Benchmark International is pleased to announce the successful transaction between the sole shareholder of OMA AG and heise & dumrath medien gmbh & co. kg. This investment marks a strategic and geographic expansion for the heise group.
Benchmark International Successfully Facilitated the Transaction Between Precise Bioscience, LLC and New Horizon Medical Solutions
Precise Bioscience was founded in 2018 and is headquartered in Durham, North Carolina. As a global leader in wound care and sports medicine, Precise Bioscience offers a variety of advanced products built on lyophilized amniotic membrane technology. The company enables physicians to provide optimal patient outcomes through innovative allograft solutions that support regenerative healing by harnessing the body’s natural restorative capabilities.
Benchmark International Successfully Facilitated the Transaction of Dock 365 Inc. and Aries Global
enchmark International is pleased to announce the successful transaction between Dock 365 Inc. and Aries Global.
Benchmark International Successfully Facilitated the Transaction of Capitol Plastics Recycling Inc and Triumvirate Environmental
Benchmark International is pleased to announce the successful transaction between Capitol Plastics Recycling Inc. and Triumvirate Environmental.
Benchmark International Successfully Facilitated the Transaction of CR Seymour Inc. and TiER1IMPACT
Benchmark International is pleased to announce the successful transaction between CR Seymour Inc.and TiER1IMPACT.